News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
703,434 Results
Type
Article (41303)
Company Profile (262)
Press Release (661869)
Section
Business (206892)
Career Advice (2045)
Deals (35649)
Drug Delivery (96)
Drug Development (81912)
Employer Resources (172)
FDA (16260)
Job Trends (15049)
News (349278)
Policy (32934)
Tag
Academia (2642)
Alliances (50206)
Alzheimer's disease (1342)
Approvals (16241)
Artificial intelligence (207)
Bankruptcy (360)
Best Places to Work (11752)
Biotechnology (183)
Breast cancer (227)
Cancer (1732)
Cardiovascular disease (132)
Career advice (1708)
CAR-T (123)
Cell therapy (359)
Clinical research (65893)
Collaboration (669)
Compensation (370)
COVID-19 (2632)
C-suite (166)
Data (1642)
Diabetes (214)
Diagnostics (6384)
Earnings (85766)
Employer resources (149)
Events (112728)
Executive appointments (572)
FDA (17171)
Funding (619)
Gene therapy (251)
GLP-1 (668)
Government (4428)
Healthcare (19041)
Infectious disease (2746)
Inflammatory bowel disease (124)
Interviews (314)
IPO (16529)
Job creations (3743)
Job search strategy (1457)
Layoffs (448)
Legal (8028)
Lung cancer (257)
Manufacturing (238)
Medical device (13390)
Medtech (13395)
Mergers & acquisitions (19497)
Metabolic disorders (556)
Neuroscience (1753)
NextGen: Class of 2025 (6602)
Non-profit (4615)
Northern California (2101)
Obesity (311)
Opinion (195)
Patents (162)
People (58190)
Phase I (20537)
Phase II (29017)
Phase III (21592)
Pipeline (714)
Postmarket research (2605)
Preclinical (8754)
Radiopharmaceuticals (243)
Rare diseases (329)
Real estate (6017)
Regulatory (22186)
Research institute (2415)
Resumes & cover letters (353)
Southern California (1803)
Startups (3666)
United States (18635)
Vaccines (623)
Weight loss (212)
Date
Last 7 days (601)
Last 30 days (2491)
Last 365 days (34804)
2025 (4479)
2024 (35665)
2023 (40538)
2022 (51705)
2021 (56282)
2020 (54644)
2019 (47235)
2018 (35590)
2017 (32720)
2016 (32197)
2015 (38237)
2014 (31924)
2013 (26988)
2012 (29111)
2011 (29775)
2010 (27852)
Location
Africa (742)
Arizona (211)
Asia (38227)
Australia (6283)
California (4790)
Canada (1726)
China (394)
Colorado (217)
Connecticut (235)
Europe (83202)
Florida (689)
Georgia (167)
Illinois (463)
Indiana (260)
Maryland (747)
Massachusetts (3665)
Michigan (200)
Minnesota (341)
New Jersey (1354)
New York (1368)
North Carolina (857)
Northern California (2101)
Ohio (173)
Pennsylvania (1103)
South America (1124)
Southern California (1803)
Texas (706)
Utah (145)
Washington State (472)
703,434 Results for "frontier scientific inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Avirmax Inc. to Present at the ARVO Frontiers in Ocular Gene Therapy Research Conference
November 12, 2024
·
2 min read
Press Releases
Brenus Pharma Publishes Promising Proof of Concept Results of their Therapeutic Platform in the Scientific Frontiers in Oncology Journal. (1)
November 7, 2024
·
2 min read
Press Releases
Phio Pharmaceuticals Announces Publication in Frontiers in Immunology
Journal is the official publication of the International Union of Immunological Societies
December 12, 2024
·
4 min read
Press Releases
Quince Therapeutics Announces Frontiers in Neurology Publication of Long-Term Safety of EryDex in Pediatric Patients with Ataxia-Telangiectasia
January 27, 2025
·
8 min read
Lone Star Bio
Coya Therapeutics Announces Publication of ALS Study in Peer-Reviewed Journal Frontiers in Neurology
Coya Therapeutics, Inc. announces the publication of a peer-reviewed manuscript titled, “A Phase 1 Proof-of-Concept Study Evaluating Safety, Tolerability, and Biological Marker Responses with Combination Therapy of CTLA4-Ig and Interleukin-2 in Amyotrophic Lateral Sclerosis,” in the medical journal Frontiers in Neurology.
June 11, 2024
·
13 min read
Press Releases
Frontier Medicines to Present at the 43rd Annual J.P. Morgan Healthcare Conference
January 9, 2025
·
1 min read
Oncoinvent to Present at Cantor Fitzgerald Frontiers in Radiopharma Virtual Summit
Oncoinvent AS today announced that members of management will participate in a virtual fireside chat at the Cantor Fitzgerald Frontiers in Radiopharma Virtual Summit on Monday, May 20, 2024 at 9:00 a.m. ET.
May 15, 2024
·
2 min read
Genetown
KalVista Pharmaceuticals Announces Publication of First Oral Factor XIIa Data in Frontiers in Pharmacology
KalVista Pharmaceuticals, Inc. (NASDAQ: KALV) today announced that data from the first report of an oral, potent, and selective FXIIa inhibitor has been published in the peer-reviewed scientific journal, Frontiers in Pharmacology.
December 20, 2023
·
3 min read
Business
Frontier Medicines Appoints Gerardo Ubaghs as Chief Financial Officer and Announces $20 Million Series C Extension
Frontier Medicines Corporation announced the appointment of Gerardo Ubaghs as Chief Financial Officer and the additional close of $20 million extension to its Series C, bringing the total amount raised to $100 million, with the financing slated to accelerate multiple pipeline programs.
June 25, 2024
·
3 min read
BioForest
Indapta Therapeutics to Highlight its g-NK Cell Platform for the Treatment of Cancer and Autoimmune Disease in a Plenary Session at New York Academy of Sciences Frontiers in Cancer Immunotherapy Conference
Indapta Therapeutics, Inc. announced that CEO Mark Frohlich, MD, will be giving a plenary talk today titled, “g-NK cells for the treatment of cancer and autoimmune disease” at the New York Academy of Sciences Frontiers in Cancer Immunotherapy Conference.
May 23, 2024
·
3 min read
1 of 70,344
Next
